A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome

[1]  D. Thomas,et al.  Breast cancer in men: risk factors with hormonal implications. , 1992, American journal of epidemiology.

[2]  J. Griffin.  Androgen resistance--the clinical and molecular spectrum. , 1992, The New England journal of medicine.

[3]  D. Housman,et al.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.

[4]  D. Housman,et al.  WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour , 1991, Nature.

[5]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[6]  D. Thomas,et al.  Breast cancer in men: aspects of familial aggregation. , 1991, Journal of the National Cancer Institute.

[7]  J. Wilson,et al.  Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. , 1991, The Journal of clinical investigation.

[8]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[9]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[10]  R. W. Crichlow,et al.  Male breast cancer. , 1990, The Surgical clinics of North America.

[11]  G. Verdi,et al.  Familial male breast carcinoma , 1990, Cancer.

[12]  A. Auquier,et al.  Risk factors for male breast cancer: A Franco‐Swiss case‐control study , 1990, International journal of cancer.

[13]  K. Yamamoto,et al.  Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. , 1989, Genes & development.

[14]  P. Chambon,et al.  Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element , 1989, Nature.

[15]  P. Chambon,et al.  The N‐terminal DNA‐binding ‘zinc finger’ of the oestrogen and glucocorticoid receptors determines target gene specificity. , 1988, The EMBO journal.

[16]  Rosenberg Dp.  Endocrine epidemiology of male breast cancer (review). , 1988 .

[17]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[18]  H. Bingham.  Familial breast cancer in males , 1987 .

[19]  J. Simpson,et al.  Abnormal sexual differentiation and neoplasia. , 1987, Cancer genetics and cytogenetics.

[20]  F. Kozak,et al.  Familial breast cancer in males: A case report and review of the literature , 1986, Cancer.

[21]  M. Frydman,et al.  Uncomplicated familial hypospadias: evidence for autosomal recessive inheritance. , 1985, American journal of medical genetics.

[22]  J. Forbes,et al.  FAMILIAL MALE BREAST CANCER , 1976, The Lancet.

[23]  J. Fraumeni,et al.  FAMILIAL MALE BREAST CANCER , 1976, The Lancet.

[24]  J. Fischer,et al.  Breast cancer in brothers Case reports and a review of 30 cases of male breast cancer , 1975, Cancer.

[25]  E. Harris.  Genetic epidemiology of hypospadias. , 1990, Epidemiologic reviews.